Optimism Foundation to sell $89 million worth of OP tokens in private sale to unknown buyer
Quick Take: Optimism Foundation announced it is privately selling roughly 19.5 million governance tokens. Neither the terms of the private sale nor the identity of the buyer have been disclosed. The tokens will be subject to a lockup period of two years.
The terms of the private sale and the identity of the buyer have not been disclosed.
The tokens will be subject to a lockup period of two years, according to an official announcement , but the purchaser will still be able to delegate tokens to unaffiliated third parties for governance votes. "Optimism has entered into a private token sale of approximately 19.5M OP tokens," the announcement posted on Optimism's governance forum read.
The project claims "the tokens come from the unallocated portion of the OP token treasury, and are part of the Foundation's original working budget of 30% of the initial OP token supply."
Optimism also notified that several transactions related to the private sale will occur in the coming days.
This was not the first time the foundation revealed a private token sale. It sold 116 million OP tokens in September 2023, valued at over $160 million at the time.
'Bad taste'
The news of the latest OP private sale has not been universally well-received by the wider Ethereum community.
The Daily Gwei founder Anthony Sassano shared his opinion that "private sales with zero transparency like this just leave a really bad taste in my mouth" on X.
Another X user sarcastically claimed : "It's not dumping if it's a private sale. Right?"
Despite some unfavorable opinions, the price of Optimism's OP token is up nearly 3% over the past 24 hours, according to The Block's price data.
OP token's price chart | The Block
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
Crypto prices
More
